Clinical trial

Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

NCT02749032

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-11-01

PhasePHASE1

Study timeline

Study start (unknown)2011-11-01Date precision: month

Registry last updated2016-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

Mixed meal testOTHER

VildagliptinDRUG

SitagliptinDRUG · verified · RxNorm: sitagliptin

PlaceboDRUG

MetforminDRUG · verified · RxNorm: metformin

Diet and exerciseOTHER

Sponsors & collaborators

Michael A. Naucklead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02749032 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.